Angeles Wealth Management LLC Sells 4,145 Shares of Cigna Group $CI

Angeles Wealth Management LLC reduced its holdings in Cigna Group (NYSE:CI) by 52.4% in the first quarter, HoldingsChannel reports. The firm owned 3,772 shares of the health services provider’s stock after selling 4,145 shares during the period. Angeles Wealth Management LLC’s holdings in Cigna Group were worth $1,006,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also recently modified their holdings of the business. Wilkerson Advisory Group LLC bought a new stake in shares of Cigna Group in the 4th quarter valued at $25,000. Beacon Financial Strategies CORP bought a new position in Cigna Group during the fourth quarter worth $28,000. Kemnay Advisory Services Inc. acquired a new stake in Cigna Group in the fourth quarter worth $29,000. Prosperity Bancshares Inc acquired a new stake in Cigna Group in the fourth quarter worth $29,000. Finally, Cedar Mountain Advisors LLC increased its stake in Cigna Group by 161.9% in the first quarter. Cedar Mountain Advisors LLC now owns 110 shares of the health services provider’s stock valued at $29,000 after purchasing an additional 68 shares in the last quarter. 86.99% of the stock is currently owned by institutional investors.

Insiders Place Their Bets

In related news, CAO Jamie G. Kates sold 899 shares of the business’s stock in a transaction dated Friday, June 12th. The shares were sold at an average price of $298.61, for a total value of $268,450.39. Following the transaction, the chief accounting officer directly owned 2,368 shares of the company’s stock, valued at approximately $707,108.48. The trade was a 27.52% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CEO David Cordani sold 201,878 shares of the stock in a transaction dated Tuesday, May 12th. The shares were sold at an average price of $292.82, for a total transaction of $59,113,915.96. Following the transaction, the chief executive officer owned 34,337 shares of the company’s stock, valued at approximately $10,054,560.34. The trade was a 85.46% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders own 0.60% of the company’s stock.

Cigna Group Price Performance

Shares of NYSE CI opened at $281.72 on Friday. Cigna Group has a twelve month low of $239.51 and a twelve month high of $315.47. The stock’s 50 day moving average price is $286.68 and its 200-day moving average price is $280.40. The company has a market capitalization of $74.52 billion, a PE ratio of 11.94, a PEG ratio of 1.09 and a beta of 0.29. The company has a quick ratio of 0.73, a current ratio of 0.73 and a debt-to-equity ratio of 0.69.

Cigna Group (NYSE:CI) last issued its quarterly earnings results on Thursday, April 30th. The health services provider reported $7.79 EPS for the quarter, beating analysts’ consensus estimates of $7.60 by $0.19. The company had revenue of $68.52 billion during the quarter, compared to the consensus estimate of $66.29 billion. Cigna Group had a return on equity of 19.75% and a net margin of 2.26%.Cigna Group’s revenue was up 4.6% on a year-over-year basis. During the same period last year, the business posted $6.74 earnings per share. Cigna Group has set its FY 2026 guidance at 30.350- EPS. On average, equities analysts anticipate that Cigna Group will post 30.39 EPS for the current year.

Cigna Group Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Thursday, June 18th. Stockholders of record on Thursday, June 4th were paid a dividend of $1.56 per share. This represents a $6.24 dividend on an annualized basis and a dividend yield of 2.2%. The ex-dividend date was Thursday, June 4th. Cigna Group’s payout ratio is presently 26.45%.

Wall Street Analysts Forecast Growth

A number of research firms have recently issued reports on CI. Mizuho increased their price objective on shares of Cigna Group from $330.00 to $340.00 and gave the stock an “outperform” rating in a research report on Monday, June 8th. Cantor Fitzgerald boosted their target price on Cigna Group from $325.00 to $340.00 and gave the company an “overweight” rating in a research report on Friday, May 1st. Barclays downgraded Cigna Group from an “overweight” rating to an “equal weight” rating and dropped their price target for the stock from $310.00 to $304.00 in a research note on Tuesday, May 26th. Wolfe Research reissued an “outperform” rating and issued a $315.00 price objective on shares of Cigna Group in a research note on Tuesday, June 16th. Finally, Wall Street Zen upgraded Cigna Group from a “hold” rating to a “buy” rating in a report on Saturday, June 20th. One equities research analyst has rated the stock with a Strong Buy rating, fifteen have assigned a Buy rating and six have given a Hold rating to the stock. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $338.80.

Cigna Group Company Profile

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.